X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5543) 5543
Newspaper Article (344) 344
Publication (265) 265
Newsletter (228) 228
Book / eBook (209) 209
Book Review (179) 179
Magazine Article (167) 167
Trade Publication Article (58) 58
Book Chapter (52) 52
Dissertation (12) 12
Conference Proceeding (8) 8
Reference (3) 3
Transcript (2) 2
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4055) 4055
urinary incontinence (3282) 3282
female (2878) 2878
index medicus (2253) 2253
urology & nephrology (2097) 2097
middle aged (1837) 1837
aged (1823) 1823
male (1756) 1756
overactive bladder (1396) 1396
adult (1362) 1362
treatment outcome (1136) 1136
bladder (1046) 1046
women (1026) 1026
care and treatment (900) 900
quality of life (868) 868
urology (854) 854
medicine & public health (823) 823
urinary bladder, overactive - drug therapy (820) 820
drug therapy (819) 819
incontinence (712) 712
aged, 80 and over (698) 698
quality-of-life (662) 662
obstetrics & gynecology (626) 626
urinary incontinence - drug therapy (612) 612
urinary-incontinence (592) 592
urodynamics (584) 584
efficacy (577) 577
muscarinic antagonists - therapeutic use (561) 561
analysis (534) 534
urinary incontinence - therapy (528) 528
prevalence (501) 501
health aspects (460) 460
symptoms (445) 445
double-blind (440) 440
animals (434) 434
prospective studies (433) 433
surgery (410) 410
gynecology (408) 408
management (403) 403
oxybutynin (391) 391
urge incontinence (382) 382
tolterodine (381) 381
surveys and questionnaires (374) 374
detrusor overactivity (365) 365
urinary incontinence - physiopathology (361) 361
pharmacology & pharmacy (360) 360
research (357) 357
risk factors (351) 351
adolescent (343) 343
urinary bladder - physiopathology (336) 336
double-blind method (331) 331
urinary bladder (331) 331
urinary incontinence - etiology (329) 329
medicine, general & internal (327) 327
diagnosis (325) 325
follow-up studies (319) 319
child (300) 300
retrospective studies (298) 298
urinary bladder, overactive - physiopathology (298) 298
urology/andrology (298) 298
therapy (292) 292
urogenital system (288) 288
clinical trials (286) 286
tolterodine tartrate (277) 277
urinary-tract symptoms (276) 276
urinary bladder - drug effects (270) 270
urinary incontinence - diagnosis (265) 265
time factors (258) 258
urinary bladder, overactive - therapy (258) 258
benign prostatic hyperplasia (246) 246
medical research (241) 241
severity of illness index (239) 239
safety (236) 236
abridged index medicus (232) 232
young adult (228) 228
stress urinary incontinence (227) 227
benzhydryl compounds - therapeutic use (226) 226
urinary tract infections (226) 226
cholinergic antagonists - therapeutic use (224) 224
geriatrics & gerontology (219) 219
muscarinic antagonists - adverse effects (219) 219
internal medicine (217) 217
botulinum toxin (213) 213
lower urinary tract symptoms (213) 213
patient satisfaction (209) 209
muscarinic antagonists - administration & dosage (204) 204
neuromodulation (204) 204
patients (203) 203
urine (200) 200
impact (199) 199
children (196) 196
lower urinary-tract (196) 196
cresols - therapeutic use (194) 194
rats (193) 193
mandelic acids - therapeutic use (192) 192
urinary incontinence - epidemiology (192) 192
drugs (190) 190
dysfunction (190) 190
medicine, experimental (190) 190
urinary incontinence, stress - therapy (189) 189
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (178) 178
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Holland Bloorview Kids Rehabilitation - Stacks (7) 7
Scarborough Hospital - General (6) 6
Providence Healthcare - Stacks (5) 5
Baycrest Hospital - Stacks (3) 3
Online Resources - Online (3) 3
Providence Healthcare - Reference (3) 3
Toronto East General Hospital - Stacks (3) 3
Credit Valley Hospital - Reference (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
St. Michael's Hospital - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Baycrest Hospital - Wellness Library (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Law (Bora Laskin) - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Providence Healthcare - Reserve desk (1) 1
Robarts - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
UofT Schools - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
West Park Healthcare Centre - Hospital Department (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6372) 6372
German (109) 109
French (30) 30
Japanese (24) 24
Spanish (20) 20
Russian (15) 15
Czech (5) 5
Dutch (5) 5
Italian (4) 4
Korean (4) 4
Polish (4) 4
Danish (3) 3
Portuguese (3) 3
Turkish (3) 3
Bulgarian (2) 2
Chinese (2) 2
Swedish (2) 2
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Urology, ISSN 0302-2838, 2013, Volume 64, Issue 2, pp. 249 - 256
Abstract Background Overactive bladder (OAB) syndrome with urinary incontinence (UI) is prevalent in the population and impairs health-related quality of life... 
Urology | Urinary incontinence | OnabotulinumtoxinA | Overactive bladder | Botulinum toxin | POPULATION | EFFICACY | TRACT SYMPTOMS | BOTULINUM-TOXIN | DOSE-RANGING TRIAL | WOMEN | IMPACT | UROLOGY & NEPHROLOGY | QUESTIONNAIRE | ANTICHOLINERGIC THERAPY | United States | Humans | Middle Aged | Urodynamics - drug effects | Male | Neuromuscular Agents - therapeutic use | Botulinum Toxins, Type A - administration & dosage | Urinary Bladder - innervation | Botulinum Toxins, Type A - therapeutic use | Urinary Bladder, Overactive - drug therapy | Urinary Bladder, Overactive - psychology | Time Factors | Urinary Bladder, Overactive - physiopathology | Urination - drug effects | Neuromuscular Agents - administration & dosage | Adult | Female | Surveys and Questionnaires | Urinary Incontinence, Urge - drug therapy | Urinary Incontinence, Urge - physiopathology | Cholinergic Antagonists - therapeutic use | Botulinum Toxins, Type A - adverse effects | Urinary Bladder, Overactive - diagnosis | Double-Blind Method | Europe | Treatment Outcome | Urinary Incontinence, Urge - psychology | Injections, Intramuscular | Urinary Incontinence, Urge - diagnosis | Neuromuscular Agents - adverse effects | Quality of Life | Urinary Bladder - physiopathology | Urinary Bladder - drug effects | Aged | Clinical trials | Incontinence | Care and treatment
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 19, pp. 1803 - 1813
Journal Article
Journal Article
Journal Article
International Urogynecology Journal, ISSN 0937-3462, 5/2016, Volume 27, Issue 5, pp. 723 - 733
Journal Article
EUROPEAN UROLOGY, ISSN 0302-2838, 02/2013, Volume 63, Issue 2, pp. 283 - 295
Journal Article
European Urology, ISSN 0302-2838, 2012, Volume 62, Issue 3, pp. 507 - 514
Abstract Background Emerging data suggest botulinum toxin is an effective treatment for detrusor overactivity (DO), but large studies confirming efficacy and... 
Urology | Incontinence | Detrusor overactivity | Botulinum toxin | Randomised trial | Idiopathic | ANTIMUSCARINIC AGENT | EFFICACY | SAFETY | TOLTERODINE | SOLIFENACIN | URGE URINARY-INCONTINENCE | TOLERABILITY | ANTICHOLINERGIC DRUGS | UROLOGY & NEPHROLOGY | BLADDER | Multivariate Analysis | Humans | Middle Aged | Urodynamics - drug effects | Neuromuscular Agents - therapeutic use | Botulinum Toxins, Type A - administration & dosage | Recovery of Function | Botulinum Toxins, Type A - therapeutic use | Urinary Bladder, Overactive - drug therapy | Time Factors | Urinary Bladder, Overactive - physiopathology | Neuromuscular Agents - administration & dosage | Female | Urinary Incontinence, Urge - drug therapy | Urinary Incontinence, Urge - physiopathology | Odds Ratio | Botulinum Toxins, Type A - adverse effects | Urinary Bladder, Overactive - complications | Urinary Bladder, Overactive - diagnosis | Double-Blind Method | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Linear Models | Treatment Outcome | United Kingdom | Chi-Square Distribution | Urinary Catheterization | Urinary Tract Infections - etiology | Neuromuscular Agents - adverse effects | Urinary Bladder - physiopathology | Urinary Bladder - drug effects | Aged | Urinary Incontinence, Urge - etiology | Administration, Intravesical | Clinical trials
Journal Article
Journal Article